Brought to you by 
Knight grosses $Cdn180mm in special warrant sale, the second this month
21 Mar 2014
Executive Summary
Infectious disease-focused Knight Therapeutics Inc. grossed $Cdn180mm ($161mm) through a private placement of 34.3mm special warrants at $Cdn5.25. At no cost, each special warrant can be exercised for one Knight common share either on a date no later than the fifth business day after the final prospectus is issued, or four months and one day after the offering closes, whichever is earlier. An affiliate owned by Knight’s CEO agreed to purchase 7.62mm special warrants, worth about $Cdn40mm. Earlier this month, Knight grossed $Cdn75mm in a separate special warrant financing.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Knight grosses $Cdn180mm in special warrant sale, the second this month
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice